Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 8699.63 is 12% below its estimated 1-year average of 9868.69, near the low end of its estimated 1-year range (8606.57–11320.35).
As of 2026-10-06T13:35:55.668Z.
Calculation as of: 2026-10-06T13:35:55.668Z.
Quote observation: 2026-10-06T13:32:48.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: aba6dde202523e327e8df603f06c84cdc8b0caa676e2570b33753db7f555988b
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
8699.63
PS RATIO AVG TTM
N/A
PS RATIO AVG 3Y
N/A
PS RATIO AVG 5Y
N/A
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.02
median of 359 covered companies
CURRENT VS SECTOR MEDIAN
+216308.71%
vs the sector median at left
Market Cap
$9.62M
PS Ratio
5.62
TTM Avg
39.64
3Y Avg
50.81
5Y Avg
50.81
Market Cap
$10.68M
PS Ratio
35.76
TTM Avg
104.45
3Y Avg
295.11
5Y Avg
603.14
Market Cap
$10.86M
PS Ratio
N/A
TTM Avg
32.91
3Y Avg
62.07
5Y Avg
66.46
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caring Brands, Inc. (CABR) | $10.09M | 8699.63 | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.94M | 731.04 | 337.84 | 351.63 | 923.89 |
| Lifeward Ltd. (LFWD)vs › | $9.92M | 0.45 | 0.51 | 1.36 | 4.08 |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.70M | N/A | N/A | N/A | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.62M | 5.62 | 39.64 | 50.81 | 50.81 |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $10.68M | 35.76 | 104.45 | 295.11 | 603.14 |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.86M | N/A | 32.91 | 62.07 | 66.46 |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.14M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.09M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.21M | N/A | 3.04 | 3.04 | 6193.39 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $740 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-09-30 |
| Q4 FY2025Period ended 2025-12-31 | $420 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-31 |
| Q1 FY2026Period ended 2026-03-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-31 |
| Q2 FY2026Period ended 2026-06-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $1,160 |
Current P/S: $10,091,572 market capitalization ÷ $1,160 TTM revenue = 8699.63x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T13:32:48.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
At 8699.63, P/S is at an extreme level, where the multiple carries little signal — higher than 6% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
8606.57
median
9924.69
estimated 1-year high
11320.35
P/S Ratio
8699.63
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 8761.64 |
| 2026-10-02 | 8994.25 |
| 2026-10-01 | 9226.86 |
| 2026-09-30 | 9226.86 |
| 2026-09-29 | 9459.47 |
| 2026-09-28 | 9614.55 |
| 2026-09-25 | 9614.55 |
| 2026-09-24 | 9459.47 |
| 2026-09-23 | 9692.08 |
| 2026-09-22 | 10157.30 |
| 2026-09-21 | 10079.77 |
| 2026-09-18 | 10855.13 |
| 2026-09-17 | 10467.45 |
| 2026-09-16 | 9459.47 |
| 2026-09-15 | 9149.33 |
| 2026-09-14 | 8994.25 |
| 2026-09-11 | 9226.86 |
| 2026-09-10 | 8839.18 |
| 2026-09-09 | 8684.11 |
| 2026-09-08 | 8606.57 |
| 2026-09-04 | 9769.62 |
| 2026-09-03 | 9847.16 |
| 2026-09-02 | 11320.35 |
| 2026-09-01 | 10467.45 |
| 2026-08-31 | 10389.91 |
| 2026-08-28 | 10777.60 |
| 2026-08-27 | 10700.06 |
| 2026-08-26 | 10312.38 |
| 2026-08-25 | 10002.23 |
| 2026-08-24 | 10467.45 |
| 2026-08-21 | 10002.23 |
| 2026-08-20 | 10312.38 |
| 2026-08-19 | 10777.60 |
| 2026-08-18 | 10544.99 |
| 2026-08-17 | 10312.38 |
| 2026-08-14 | 10700.06 |